EIPICO is the civilized face of EGYPT in the
EIPICO was established as a private investment
company in 1980 and started production in 1985.
EIPICO typically applies c.G.M.P. Regulations
throughout the operational departments including evaluation of raw materials,
calibration of equipments, control, holding and distribution of finished
EIPICO plant has a U-shaped design that
minimizes mix-up and/or contamination by providing a single direction of
material flow and is also surrounded by a green area as a protection from
surrounding environment. Each pharmaceutical process has enough space to be
carried out apart to minimize mix-up and/or cross contamination.
EIPICO is unique by its Sterile Areas (which are
the largest in the Middle East and North African Region) that are
environmentally controlled to obtain filtered air up to 97% - 99.7%
particulate-free. The water purification system in EIPICO
was designed to supply the production zones with demineralized and distilled
EIPICO was the Pioneer Egyptian Company to
produce dosage forms like the spansule capsules (long-acting).
EIPICO also produces the non-traditional dosage
forms such as the soft gelatin capsules, lyophilized products, gels, sprayers
and effervescent tablets. The sound management enables
EIPICO to seek the highest quality of raw material from the least
EIPICO products have been selected according to
the actual needs taking into consideration the following priorities:
-New products to replace the imported ones.
-The new technology in pharmaceutical industry and researches.
-The mutual co-operation between the Egyptian experts and researchers at
EIPICO and those of the foreign international pharmaceutical
companies according to license agreements.
Training Courses at EIPICO are of the highest
possible level of the pharmaceutical industry.
EIPICO has its own Computer Network System of
the latest generations connecting all various activities of production, storage
and administration to optimize the Q.M.S.
EIPICO is distinguished by Direct Selling
(Spot Delivery System). Its van cars cover all over Egypt.
EIPICO made License Agreements with a
group of International Pharmaceutical Companies to produce their specialties to
replace imported products, to cover the increasing demand and to acquire
technology and know- how.
EIPICO, inaugurated its Biotechnology
Center on August 6th, 2001 to contribute in the development of the drugs in all
stages such as:
- Synthesis of raw materials using biotechnology,
- Bacterial and tissue utilization to produce Biotechnology and
- Extraction of active materials from natural products.
- Pre-clinical studies including pharmacokinetics and
- Dosage forms studies including preformulation, stability studies and
new drug delivery system.
- Clinical trials.
- Technology transfer.
- Protein purification.
Due to the importance of human factor in this kind of research, the center is
training its staff in-house and outside Egypt to increase professionalism.
Due to the fact that this center is of special nature, appliances and specific
scientific apparatus in this field, it has been separated from the Research and
Control Department with a separate headcount and budget. The new products will
have a great impact medically and economically.
In 1996, EIPICO has been awarded the ISO -
9001 Certificate by the (BSI) for establishing, Implementing, and maintaining
quality assurance systems in Design, Development, Production, Installation, and
In 1999, EIPICO has also been awarded the ISO -
14001 Certificate regarding Environmental - friendly practices.
EIPICO is the largest local producer of
pharmaceuticals in Egypt.
EIPICO exports their pharmaceutical products to
Arab Countries, and to some African, Asian and East European Countries.
EIPICO is the industry leader, capturing 8%
share of the local pharmaceutical market and approximately 20% of Egypt’s total
MANAGEMENT SYSTEM (Q.M.S.)
EIPICO’s Q.M.S. meets the requirements of both:
cGMP regulations and ISO 9001, issue 2000 Standards,
EIPICO’s Q.M.S. aims to ensure that the Quality of
EIPICO’s products are:
- Conforming to the updated specific requirements.
EIPICO’s Q.M.S. is the way to keep our Quality up.
This goal is achieved only by building the Quality into the product during:
- Planning of the Infrastructure needed to achieve conforming to product
- Planning to improve competence, awareness and training to
EIPICO’s human resources.
- Customer communication.
- Research and development.
- Raw materials, packaging materials and other specific materials purchasing
- Updating the technology and manufacturing techniques.
EIPICO’s Q.M.S. is not only documented and
implemented but also its effectiveness is continuously measured, analysed and
improved through monitoring and measuring of:
- Customer satisfaction.
- Internal audits.
Q.M.S. COMPLIES WITH THE CONCEPT OF
EIPICO’s Q.M.S. promotes the adoption of a “PROCESS
APPROACH” when developing, implementing and improving the effectiveness of a
Q.M.S., to enhance customer satisfaction by meeting customer requirements.
EIPICO’s Q.M.S. identifies and manages numerous
linked activities, each activity using resources and managed in order to enable
the transformation of inputs into outputs, can be considered as a process.
Often the output from one process directly forms the input to the next.
The application of that system within EIPICO
together with the identification and interactions of these processes can be
referred to as the “PROCESS APPROACH”. The advantage of the “PROCESS APPROACH”
is that it provides the linkage between the individual processes; such approach
emphasizes the importance of :
i. Understanding and meeting requirements.
ii. Obtaining results of process performance and effectiveness.
iii. Continual improvement of processes based on objective measurement.
EIPICO’s “PROCESS APPROACH” shown in the following
figure, shows that customers play a significant role in defining requirements
EIPICO’s Q.M.S. monitors the Customer Satisfaction